| Vasudevan Kg Nair, MD | |
|
301 S Power Rd Ste 103, Mesa, AZ 85206-5243 | |
| (480) 325-7535 | |
| (480) 325-7462 |
| Full Name | Vasudevan Kg Nair |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 301 S Power Rd Ste 103, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629025796 | NPI | - | NPPES |
| Z147325 | Other | AZ | BANNER MD ANDERSON CANCER CENTER |
| 149727 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 35514 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Power Road Dialysis (dva) | Mesa, AZ | Dialysis facility |
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Dignity Health Arizona General Hospital | Mesa, AZ | Hospital |
| Mountain Vista Medical Center, Lp | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banner Cancer Center Specialists Llc | 6103097779 | 266 |
| Southwest Kidney Institute Plc | 8224930987 | 81 |
News Archive
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.
A liquid adhesive made from a protein found in human tissue is effective in sealing corneal wounds and may even be better than stitches, according to results of a Johns Hopkins study.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.
"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."
› Verified 7 days ago
| Entity Name | Southwest Kidney Institute Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659316008 PECOS PAC ID: 8224930987 Enrollment ID: O20040211001069 |
News Archive
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.
A liquid adhesive made from a protein found in human tissue is effective in sealing corneal wounds and may even be better than stitches, according to results of a Johns Hopkins study.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.
"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."
› Verified 7 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.
A liquid adhesive made from a protein found in human tissue is effective in sealing corneal wounds and may even be better than stitches, according to results of a Johns Hopkins study.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.
"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."
› Verified 7 days ago
| Entity Name | Southwest Kidney Institute Scottsdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231012 PECOS PAC ID: 3577798313 Enrollment ID: O20131101000457 |
News Archive
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.
A liquid adhesive made from a protein found in human tissue is effective in sealing corneal wounds and may even be better than stitches, according to results of a Johns Hopkins study.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.
"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vasudevan Kg Nair, MD 2149 E Warner Rd Ste 102, Tempe, AZ 85284-3495 Ph: (480) 610-6100 | Vasudevan Kg Nair, MD 301 S Power Rd Ste 103, Mesa, AZ 85206-5243 Ph: (480) 325-7535 |
News Archive
InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce the pain and inflammation associated with ocular surgery.
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.
A liquid adhesive made from a protein found in human tissue is effective in sealing corneal wounds and may even be better than stitches, according to results of a Johns Hopkins study.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, researchers find.
"For an orphan disease like Batten, which has such a clear-cut course of deterioration and no present cure, this grant is transformative both for these families and for us, as clinicians and researchers."
› Verified 7 days ago
Dr. Emmanuel A Bayongan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |